Advertisement

Comparative Clinical Pathology

, Volume 23, Issue 5, pp 1321–1330 | Cite as

Detection of human cytomegalovirus in glioma tumor tissues

  • Narges Ahani
  • Abbas Nikravesh
  • Reza Shirkoohi
  • Mohsen Karimi Arzenani
  • Mohammad Rokouei
  • Madjid Alipour Eskandani
Original Article

Abstract

A brain tumor that develops from glial cells is called a glioma. About half of all primary brain tumors form from glial cells. Gliomas are divided into subgroups, depending on the origin of the glial cells. Detection of human cytomegalovirus in tumor tissues of glioma patient was performed for the first time in Iran. These data show an association between human cytomegalovirus (HCMV) and malignant gliomas and suggest that HCMV may play an active role in glioma pathogenesis. Cytomegalovirus surgical biopsy specimens of glioma tissues (n = 28) and non-tumor brain tissues (n = 8) were obtained. Total DNA of specimens was extracted, and then, extracted DNA was evaluated by polymerase chain reaction for evidence of HCMV nucleic acids. Here, we show that a high percentage of malignant gliomas are infected by HCMV. Seventy-five percent of grade 4 glioma, 57 % of grade 3 glioma, and 33 % of grade 2 glioma were HCMV positive. All specimens of grade 1 glioma and control tissues were HCMV negative. The relationship between the grade of glioma and the presence of HCMV is significant (P value = 0.035). Fisher exact test was used for statistical analysis.

Keywords

Detection Human cytomegaloviruses Glioma PCR 

References

  1. Barami K (2010) Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci 17:819–823PubMedCrossRefGoogle Scholar
  2. Caposio P, Orloff SL, Streblow DN (2011) The role of cytomegalovirus in angiogenesis. Virus Res 157:204–211PubMedCrossRefPubMedCentralGoogle Scholar
  3. Chen I-H, Lai Y-L, Wu C-L et al (2010) Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection. Cancer Immunol Immunother 59:323–334PubMedCrossRefGoogle Scholar
  4. Cinatl J Jr, Kotchetkov R, Scholz M et al (1999) Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol 155:285–292PubMedCrossRefPubMedCentralGoogle Scholar
  5. Cobbs CS (2011) Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2(10):2–7Google Scholar
  6. Cobbs CS, Harkins L, Samanta M et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350PubMedGoogle Scholar
  7. Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH (2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724–730PubMedCrossRefGoogle Scholar
  8. Doolittle ND (2004) State of science in brain tumor classification. Semin Oncol Nurs 20:224–230PubMedCrossRefGoogle Scholar
  9. Dziurzynski K, Chang S, Heimberger A, Kalejta R, Dallas SM, Soroceanu L, Cobbs C (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14(3):246–55PubMedCrossRefPubMedCentralGoogle Scholar
  10. ElBeik T, Razzaque A, Jariwalla R, Cihlar RL, Rosenthal LJ (1986) Multiple transforming regions of human cytomegalovirus DNA. J Virol 60(2):645–652Google Scholar
  11. Luo MH, Fortunato EA (2007) Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J Virol 81:10424–10436PubMedCrossRefPubMedCentralGoogle Scholar
  12. Maussang D, Verzijl D, Walsum M, Leurs R et al (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 103(35):13068–13073PubMedCrossRefPubMedCentralGoogle Scholar
  13. Michaelis M, Baumgarten P, Mittelbronn M, Driever PH, Doerr HW, Cinatl J (2011) Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol 200:1–5PubMedCrossRefGoogle Scholar
  14. Murayama T, Ohara Y, Obuchi M, Khabar KS, Higashi H, Mukaida N, Matsushima K (1997) Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene. J Virol 71(7):5692–5695PubMedPubMedCentralGoogle Scholar
  15. Ranganathan P, Clark PA, Kuo JS, Shahriar Salamat M, Kalejta RF (2011) Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol 86(2):854–864PubMedCrossRefGoogle Scholar
  16. Richard L (2012) The role of cytomegalovirus in glioblastoma and rhabdomyosarcoma. The Ohio State University and OhioLINK, OhioGoogle Scholar
  17. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116(1):79–86PubMedCrossRefPubMedCentralGoogle Scholar
  18. Singh N, Paterson D (2000) Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplant J 69(12):2474–2479CrossRefGoogle Scholar
  19. Smirniotopoulos JG (1999) The new WHO classification of brain tumors. Neuroimaging Clin N Am 9(4):595–613PubMedGoogle Scholar
  20. Strååt K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, Liu Z (2009) Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 101(7):488–97PubMedCrossRefGoogle Scholar
  21. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99(5):511–520PubMedCrossRefGoogle Scholar
  22. Yongjun Y, Alwine JC (2002) Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J Virol 76:3731–3738CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Narges Ahani
    • 1
    • 2
  • Abbas Nikravesh
    • 3
  • Reza Shirkoohi
    • 4
  • Mohsen Karimi Arzenani
    • 5
  • Mohammad Rokouei
    • 6
  • Madjid Alipour Eskandani
    • 7
  1. 1.Faculty of ScienceUniversity of ZabolZabolIran
  2. 2.TehranIran
  3. 3.Department of Molecular Sciences, Faculty of MedicineNorth Khorasan University of Medical SciencesBojnurdIran
  4. 4.Genetic Group, Cancer Research Center, Cancer Institute of IranTehran University of Medical SciencesTehranIran
  5. 5.Department of Molecular MedicinePasteur Institute of IranTehranIran
  6. 6.Department of Animal Science, Faculty of AgricultureUniversity of ZabolZabolIran
  7. 7.Department of Food Hygiene, Faculty of Veterinary MedicineUniversity of ZabolZabolIran

Personalised recommendations